Moderna MRNA Rest of world — Total Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Moderna in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Moderna’s 10-K, filed February 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Moderna's rest of world — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Moderna's rest of world — total revenue?
- Moderna (MRNA) reported rest of world — total revenue of $173M in Q4 2025.
- How has Moderna's rest of world — total revenue changed year-over-year?
- Moderna's rest of world — total revenue decreased by 18.9% year-over-year, from $213.25M to $173M.
- What is the long-term trend for Moderna's rest of world — total revenue?
- Over 4 years (2021 to 2025), Moderna's rest of world — total revenue has grown at a -40.3% compound annual growth rate (CAGR), from $5.45B to $692M.
- What does rest of world — total revenue mean?
- This metric represents the total gross revenue generated by the company from all geographic regions excluding the primary domestic market. It reflects the company's ability to monetize its product portfolio and expand its commercial footprint on a global scale. Tracking this helps investors understand the geographic diversification of the company's sales and its reliance on international markets.